Agilent Technologies, Inc. (NYSE:A) Shares Sold by Ontario Teachers Pension Plan Board

Ontario Teachers Pension Plan Board decreased its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 4.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,794 shares of the medical research company’s stock after selling 133 shares during the period. Ontario Teachers Pension Plan Board’s holdings in Agilent Technologies were worth $375,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Flynn Zito Capital Management LLC grew its position in shares of Agilent Technologies by 3.8% during the 4th quarter. Flynn Zito Capital Management LLC now owns 1,871 shares of the medical research company’s stock valued at $251,000 after buying an additional 69 shares during the last quarter. IFP Advisors Inc boosted its stake in Agilent Technologies by 17.7% in the fourth quarter. IFP Advisors Inc now owns 458 shares of the medical research company’s stock valued at $62,000 after acquiring an additional 69 shares during the period. Tiemann Investment Advisors LLC grew its holdings in shares of Agilent Technologies by 5.6% during the fourth quarter. Tiemann Investment Advisors LLC now owns 1,423 shares of the medical research company’s stock valued at $191,000 after purchasing an additional 75 shares during the last quarter. Rothschild Investment LLC raised its position in shares of Agilent Technologies by 19.2% during the 4th quarter. Rothschild Investment LLC now owns 491 shares of the medical research company’s stock worth $66,000 after purchasing an additional 79 shares during the period. Finally, CIBC Private Wealth Group LLC lifted its holdings in shares of Agilent Technologies by 1.2% in the 4th quarter. CIBC Private Wealth Group LLC now owns 7,479 shares of the medical research company’s stock worth $1,025,000 after purchasing an additional 87 shares during the last quarter.

Agilent Technologies Stock Down 0.3 %

A opened at $102.38 on Friday. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20. The company has a market capitalization of $29.19 billion, a PE ratio of 23.54, a P/E/G ratio of 2.90 and a beta of 1.19. The stock’s fifty day moving average is $120.34 and its 200-day moving average is $132.80. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $155.35.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, topping the consensus estimate of $1.27 by $0.04. The firm had revenue of $1.68 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. On average, equities analysts predict that Agilent Technologies, Inc. will post 5.55 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be issued a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a dividend yield of 0.97%. The ex-dividend date of this dividend is Tuesday, April 1st. Agilent Technologies’s dividend payout ratio is 22.76%.

Insider Activity at Agilent Technologies

In related news, Director Daniel K. Podolsky sold 1,819 shares of the firm’s stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $116.46, for a total value of $211,840.74. Following the completion of the transaction, the director now owns 35,737 shares of the company’s stock, valued at approximately $4,161,931.02. This trade represents a 4.84 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Padraig Mcdonnell sold 1,911 shares of the business’s stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the sale, the chief executive officer now directly owns 39,652 shares in the company, valued at approximately $5,947,800. This trade represents a 4.60 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 5,638 shares of company stock worth $731,229 in the last quarter.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. Robert W. Baird lowered their price objective on Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating for the company in a research note on Thursday, February 27th. TD Cowen upped their price target on shares of Agilent Technologies to $135.00 and gave the stock a “buy” rating in a research report on Thursday, April 10th. StockNews.com upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Tuesday, December 24th. Barclays decreased their target price on shares of Agilent Technologies from $138.00 to $115.00 and set an “equal weight” rating for the company in a research report on Thursday, April 10th. Finally, Wells Fargo & Company cut their price target on Agilent Technologies from $155.00 to $135.00 and set an “overweight” rating on the stock in a report on Thursday. Seven investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $144.58.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.